Special lssues
Editorial Board
Editors-in-Chief
  • Edward Chu

    Albert Einstein College of Medicine, USA

    Interests: cancer pharmacology and drug development

  • Enrico Mini

    University of Florence Florence, ITALY

    Interests: the mechanisms of tumor drug resistance, in particular to antimetabolites and metal-based drugs, cancer pharmacogenomics and pharmacogenetics, and controlled clinical trials in gastrointestinal cancers

Editorial Board Members
  • Sirin A. Adham

    Sultan Qaboos University, OMAN

    Interests: breast cancer, integrin beta 3, chemoresistance, adriamycin, cyclophosphamide

  • Aamir Ahmad

    University of Alabama at Birmingham, USA

    Interests: cancer metastasis, drug resistance, miRNA and cancer health disparity

  • Mamoun Ahram

    The University of Jordan, JORDAN

    Interests: cancer biology, molecular and cell biology, biobanking, breast cancer, androgen

  • Dante Amelio

    Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari (APSS), ITALY

    Interests: astrocytoma, bone tumor, brain tumor, chordoma, craniopharyngioma, glioblastoma, meningioma, pituitary tumor, schwannoma

  • Roberto Bei

    Facoltà di Medicina e Chirurgia Università degli Studi di Roma Tor Vergata Rome, ITALY

    Interests: Oncology: Analysis of immune response to tumor associated antigens (ErbB receptors, AFP, CEA, PSA) in cancer patients and cancer immunotherapy. Analysis of the expression of tumor antigens in tumors and normal tissues; Virology: Production and characterization of monoclonal antibodies to viral proteins; Nutrition: Effect of natural compounds on cancer cell growth.

  • Luca Bertolaccini

    European Institute of Oncology IRCCS, ITALY

    Interests: lung cancer surgery, minimally invasive thoracic surgery, thoracic oncology, biostatistics

  • Guido Bocci

    University of Pisa, ITALY

    Interests: Cancer Biology; Clinical Studies; Pharmacodynamics; Clinical Pharmacokinetics; Pharmacokinetics; Genetics Oncology; Tumors; Cancer Research

  • George Gong CHEN

    The Chinese University of Hong Kong, HONG KONG

    Interests: head and neck cancers, especially thyroid cancer and laryngeal cancer

  • William CHO

    Queen Elizabeth Hospital, HONG KONG

    Interests: molecular biology, proteomics, genomics, immunology, bioinformatics, next-generation sequencing

  • Maria Caffo

    University of Messina, ITALY

    Interests: glioblastoma multiforme (GBM), astrocytoma, medulloblastoma, neuroradiology, magnetic resonance, glioma, molecular oncology, meningioma,neurosurgery

  • Jianyuan Chai

    Inner Mongolia University of Science and Technology, CHINA

    Interests: molecular and cellular biology of wound healing, angiogenesis, apoptosis, cancer development, esophageal cancer, gastrointestinal injury and malignancy

  • Nipon Chattipakorn

    Cardiac Electrophysiology Research and Training Center (CERT), Thailand; Faculty of Medicine, Chiang Mai University, THAILAND

    Interests: Cardio-oncology, chemotherapy-induced cardiotoxicity, mitochondria, programmed cell death, molecular cardiology

  • Xiaofang Che

    The First Hospital of China Medical University, CHINA

    Interests: tumor microenvironment, hypoxia, immunology, cancer, proliferation, drug resistance, metastasis, exosome, non-cording RNA, m6A methylation, post-translational modification, biomarker

  • Tianhui Chen

    Zhejiang Cancer Hospital, CHINA

    Interests: clinical epidemiology, molecular epidemiology, genetic epidemiology of familial cancer (colorectal cancer, breast cancer, ovarian cancer, pancreatic cancer)

  • Ting Chen

    The First Affiliated Hospital, Zhejiang University School of Medicine, CHINA

    Interests: Stem progenitor cells and vascular biology, Cancer stem cell microenvironment, mechanism of non-coding RNA in tumor angiogenesis

  • Valentina De Falco

    Consiglio Nazionale delle Ricerche, ITALY

    Interests: Molecular Oncology, Preclinical Investigation, Targeted Therapies, Kinase Inhibitors, Personalized Medicine

  • Ammad Ahmad Farooqi

    Institute of Biomedical and Genetic Engineering, PAKISTAN

    Interests: cancer genetics and therapeutics, targeting of oncogenic signaling pathways using natural products, restoration of apoptotic pathway in resistant cancers

  • Francesca De Felice

    Sapienza University of Rome, ITALY

    Interests: gastrointestinal cancers, head and neck cancers, gynecological cancers, machine learning data analysis, survival analysis

  • Vittorio Gebbia

    University of Enna Kore, ITALY

    Interests: medial oncology, hematology, lung cancer, chemotherapy

  • David A. Gewirtz

    Virginia Commonwealth University, USA

    Interests: autophagy, cell biology, programmed cell death, apoptosis and senescence

  • Bahil Ghanim

    Karl Landsteiner University of Health Sciences, AUSTRIA

    Interests: biomarkers, thoracic surgery, lung cancer, mesothelioma, minimal invasive surgery and solitary fibrous tumor of the lung

  • Sandra E. Ghayad

    Aix-Marseille Université, FRANCE

    Interests: cancer cells; cancer therapy; tumors thrombosis; senescence; exosomes; microvesicles

  • Pia Giovannelli

    University of Campania “L. Vanvitelli”, ITALY

    Interests: cancer biology, molecular biology, cancer cells, epigenetics, gene expression

  • Nocentini Giuseppe

    University of Perugia, ITALY

    Interests: pharmacology, immunotoxicology and pharmacoimmunology

  • Manuel Graeber

    The University of Sydney, AUSTRALIA

    Interests: brain tumours, glioblastoma, microglia, brain macrophages, tumour microenvironment, neurogenetics

  • Sanjay Gupta

    Case Western Reserve University, USA

    Interests: cancer biomarkers, cancer therapeutics and drug repurposing and cancer stem cells research

  • Jing He

    Guangzhou Women and Children's Medical Center, CHINA

    Interests: cancer genetics, cancer epidemiology, molecular epidemiology, cancer therapy, signal transduction, pediatric oncology, evidence-based medicine (meta-analysis), molecular biology

  • Mehdi Hedayati

    Shahid Beheshti University of Medical Sciences, Research Institute for Endocrine Science, Cellular and Molecular Endocrine Research Center, IRAN

    Interests: biochemistry and genetic aspects of thyroid cancer, biostatistics, endocrine oncology

  • Ryouichi Horie

    Kitasato University, JAPAN

    Interests: molecular hematology, medical sciences

  • Nobuyuki Horita

    Yokohama City University Hospital, JAPAN

    Interests: pulmonary disease, meta-analysis, propensity score matching, and survival analysis

  • Shen Hu

    California NanoSystems Institute, University of California, USA

    Interests: cancer metabolism, mass spectrometry based metabolomics and proteomics, nanomedicine and nanotoxicology, biomarker discovery in cancer, autoimmune and pain diseases

  • Ciro Isidoro

    Università del Piemonte Orientale, ITALY

    Interests: cancer biology, autophagy, cell death, cell biology, cancer research, apoptosis, cell proliferation

  • Makoto Kawatani

    RIKEN Center for Sustainable Resource Science (CSRS), JAPAN

    Interests: chemical biology, drug development and cancer research

  • Shirabe Ken

    Graduate School of Medical Sciences Fukuoka, JAPAN

    Interests: Hepato-pancreato-biliary Surgery, Liver Transplantation Surgery

  • Cheorl-Ho Kim

    Sungkyunkwan University, KOREA

    Interests: innate immunity; microbe-host interasction; angiogensis; differentiation; invasion; ethnopharmcology; molecular and cellular glycobiology; cancer research

  • Marina Kriajevska

    University of Leicester, UK

    Interests: cell signaling, bladder cancer

  • Tao Li

    Qilu Hospital, Shandong University, CHINA

    Interests: the biology and treatment of Hepatobiliary tumors

  • Chien-Feng Li

    Chi Mei Medical Center, TAIWAN

    Interests: the effect of genetic, epigenetic, expression, and metabolic alternations on cancer progression and metastasis

  • Yingying Lin

    Shanghai Jiaotong University, CHINA

    Interests: tumor microenvironment, protease, glioma

  • Tao Liu

    Lowy Cancer Research Centre, AUSTRALIA

    Interests: oncology and carcinogenesis, cancer cell biology, cancer genetics, cancer therapy

  • Jinhui Liu

    The First Affiliated Hospital of Nanjing Medical University, CHINA

    Interests: biomarker, prognostic model, non-coding RNA, machine learning, bioinformatics, immunology

  • Ying Liu

    Qingdao University, CHINA

    Interests: basic and applied research on nuclear receptor signal transduction, protein post-translational modification, identification of tumor biomarkers, and bioinformatics

  • Cesar Lopez-Camarillo

    Universidad Autónoma de la Ciudad de México Mexico, MEXICO

    Interests: microRNAs, lncRNAs and proteins deregulated in cancer using diverse omics approaches (genomics, proteomics, expression profiling, etc).

  • Wenxue Ma

    University of California, USA

    Interests: cancer stem cell (CSC), cancer immunotherapy, antigen presentation, tumor neoantigens, Cytotoxic T-Lymphocytes (CTLs), tumor-infiltrating lymphocytes (TILs), dug delivery with nanotechnology (Nanomedicine), targeted cancer therapy, circulating tumor cell (CTC), biomarkers

  • Sebastiano Mercadante

    La Maddalena Cancer Center, ITALY

    Interests: cancer pain, palliative medicine, anesthesiology

  • Constantinos Mikelis

    University of Patras, GREECE

    Interests: investigating the role of the small GTPase RhoA on developmental and tumor-induced angiogenesis, lymphangiogenesis, on the role of endothelial RhoA on cancer cell trans-endothelial migration, signaling circuits, genetic alterations taking place in the endothelium upon incorporation of cancer-derived exosomes, as part of the pre-metastatic niche

  • Isao Momose

    Institute of Microbial Chemistry, JAPAN

    Interests: bioorganic chemistry; applied biochemistry and applied microbiology

  • Giovanni Monteleone

    University of Rome Tor Vergata, ITALY

    Interests: gastroenterology, cancer immunity and immunotherapy, liver and clinical research

  • Yuseok Moon

    Pusan National University, KOREA

    Interests: Microbiology, Cell Biology, Molecular Biology, Toxicology, Immunology

  • Luca Maria Munaron

    University of Torino, ITALY

    Interests: tumor-derivedendothelial cells, drugdelivering against tumor vascularization and Bone vascularization and biomaterials

  • Yasser Fakhri Mustafa

    University of Mosul, IRAQ

    Interests: drug design, pharmaceutical chemistry, cancer therapy

  • Calvin Sze Hang Ng

    Chinese University of Hong Kong, HONG KONG

    Interests: lung cancer, tumor biology, metastasis, video-assisted thoracic surgey, clinical oncology

  • Hiroyuki Osada

    RIKEN Center for Sustainable Resource Science (CSRS), JAPAN

    Interests: chemical biology research

  • Chunlin Ou

    Xiangya Hospital, Central South University, CHINA

    Interests: the regulatory mechanism of non-coding RNAs in cancers, clinical application of mRNA vaccine in cancers.

  • Mohammad Oves

    King Abdulaziz University, SAUDI ARABIA

    Interests: multidrug resistance, antimicrobial agents and nanomaterials bio-fabrication, biofilm, chromium reduction and phosphate solubilization microbe

  • Petar Ozretić

    Laboratory for Hereditary Cancer, Ruđer Bošković Institute (RBI), CROATIA

    Interests: cancer genetics, epigenetics, bioinformatics, biostatistics and molecular oncology

  • Pierlorenzo Pallante

    IEOS, Consiglio Nazionale delle Ricerche (CNR), ITALY

    Interests: non-coding RNA, cancer biology, biomarkers, cell biology, cancer therapy, prognosis, pharmacology, cancer chemotherapy, translational research in the field of lung and colorectal oncology

  • Roberto Passera

    University of Torino, AOU Città della Salute e della Scienza (Molinette Hospital), ITALY

    Interests: cancer clinical epidemiology and biostatistics, systematic reviews and meta-analyses in surgical oncology, chemo- and immunochemo- regimens in onco-hematology, new biomarkers for prostate cancer, pharmacokinetic and pharmacodynamic trials in oncology

  • Alfons Navarro Ponz

    University of Barcelona, SPAIN

    Interests: non-coding RNAs in solid and hematologic cancers, including colorectal cancer, non-small-cell lung cancer, Hodgkin lymphoma, acute myeloid leukemia, and multiple myeloma

  • Mohammad Rahimi-Gorji

    Ghent University, BELGIUM

    Interests: cancer and tumor modeling, drug delivery, intraperitoneal chemotherapy, CFD simulation of drug delivery, biomedical modeling 

  • Leonardo Oliveira Reis

    Pontifical Catholic University of Campinas, BRAZIL

    Interests: prostate cancer; urologic surgical; bladder cancer; cancer diagnostics; urologic oncology; cryosurgery; translational research; evidence based medicine; hydronephrosis

  • Hasan Mahmud Reza

    North South University, BANGLADESH

    Interests: pharmaceutical dosage form development, pharmacological studies with natural products and available molecules using animal disease models, molecular biology and biochemistry, cell culture

  • Antonio Ruggiero

    Fondazione Policlinico Universitario Gemelli IRCCS, ITALY

    Interests: pediatric clinical trials, clinical pharmacology of antineoplastic drugs, pain therapy and pediatric drugs

  • Belgin SEVER

    Anadolu Üniversitesi, TURKEY

    Interests: targeted anticancer drug development; medicinal chemistry; computational chemistry; QSAR; molecular modelling; molecular simulations; virtual screening; in silico ADME analysis; drug design and development

  • Consolato Sergi

    University of Ottawa, CANADA

    Interests: biology and pathology of the cardiovascular, gastrointestinal System and gut, bile microbiome, bone cell biology, pediatric pathology with nanotech applications for oncology

  • Wunchana Seubwai

    Khon Kaen University, THAILAND

    Interests: cancer biology, cell signaling,cell culture, immunohistochemistry, apoptosis, cell proliferation, biochemistry, cancer cell biology, molecular cell biology, gene expression

  • Hong Shen

    Xiangya Hospital, Central South University, CHINA

    Interests: tumor microenvironment, immunotherapy, tumor metabolism, epigenetic therapy, single-cell sequencing, cell proliferation, tumor metastasis

  • Zhendong Shi

    Tianjin Medical University Cancer Institute and Hospital,CHINA

    Interests: Clinical Immunology, Oncology, Nanomedicine, Breast cancer

  • Alexander Shtil

    Blokhin Cancer Center, RUSSIA

    Interests: mechanisms of tumor cell death, drug resistance, antitumor drug design

  • Yang Shun-Fa

    Chung Shan Medical University, Taichung, TAIWAN

    Interests: pharmacology, oral cancer metastasis, cancer biology, genetic polymorphism and environment risk factors in oral cancer

  • Jianxun Jim Song

    Texas A&M University Health Science Center, USA

    Interests: T cell biology, immunotherapy, stem cells, cancer, autoimmunity, cell metabolism, signal transduction

  • Stefania Nobili

    University of Florence, ITALY

    Interests: pharmacology, applied pharmacology

  • Hailin Tang

    Sun Yat-sen University Cancer Center, CHINA

    Interests: cancer, metastasis, therapy, animal model, Non-coding RNA

  • Yong Teng

    Emory University School of Medicine, USA

    Interests: tumor microenvironment, tumor metabolism, and metastasis with an emphasis on molecular determinants

  • Chin-Hsiao Tseng

    National Taiwan University Hospital, TAIWAN

    Interests: diabetes, arsenic-related health hazards, cancer issues related to diabetes and antidiabetic drugs

  • Hardeep Singh Tuli

    Maharishi Markandeshwar University, INDIA

    Interests: cordyceps, nanoparticles, cancer biology, microbial biotechnology, cell cycle, therapeutics

  • Jinhua Wang

    National Center for Pharmaceutical Screening, Institute of Materia Medica, CHINA

    Interests: the mechanism and drug targets of cancers

  • Jaw-Yuan Wang

    Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Chong-Ho Memorial Hospital, Taiwan

    Interests: Surgical and Molecular oncology, Colorectal cancer, Gastrointestinal malignancy and disease, Nutrition therapy, Robotic surgery, Microbiota

  • Ning Wei

    Montefiore Einstein Cancer Center, USA

    Interests: cancer pharmacology and drug discovery

  • Serge Weis

    Johannes Kepler University, AUSTRIA

    Interests: neurodegeneration,biological psychiatry, neuro-oncology, neuro-AIDS, temporal lobe epilepsy, neuromuscular, drug abuse and brain pathology, stroke and chlamydia, development of the human brain,sexual dimorphism, cerebral asymmetries, neuro-imaging and morphometry in micronanatomic neurosurgery, pituitary gland

  • Guoxiong Xu

    Research Center for Clinical Medicine, Jinshan Hospital, Fudan University

    Interests: Oncology, Physiology, Cell Biology, Molecular Biology, Apoptosis, Cell Signaling, Cancer Biology, Cell Proliferation, Cancer Biomarkers

  • Yohko Yamazaki

    Institute of Microbial Chemistry, JAPAN

    Interests: androgen receptors, prostate cancer, anticancer drugs and phospholipid remodeling

  • Young Yang

    Sookmyung Women's University Seoul, SOUTH KOREA

    Interests: Tumor EMT&MET; Mesenchymal Stem cells and Immune regulation; Bone Homeostatsis; Metabolic rewiring

  • Hooman Yarmohammadi

    Memorial Sloan-Kettering Cancer Center, USA

    Interests: diagnostic radiology; diagnosis; pancreatic cancer; interventional radiology; endovascular procedures; tumors; lung; cancer biology; animal studies

  • Zhiling Yu

    Hong Kong Baptist University Hong Kong, HONG KONG

    Interests: Melanoma; Atopic dermatitis; Cancer; Skin care; Pharmacology; Inflammation

  • Xu Dong Zhang

    University of Newcastle, AUSTRALIA

    Interests: melanoma, pancreatic, colorectal & rare cancers

  • Shuyu Zhang

    Sichuan University, CHINA

    Interests: tumor radiosensitivity mechanisms and nuclear radiation damage prevention strategies

Early Career Editorial Board Member
  • Chavda Vivek Prakash Bhai

    L.M. College of Pharmacy, INDIA

    Interests: complex injectable, biologics, immunotherapy and vaccine

  • Jiyoon Bu

    INHA University, KOREA

    Interests: drug delivery, nano engineering, liquid biopsy, immunotherapy

  • Gerardo Cazzato

    University of Bari "Aldo Moro", ITALY

    Interests: lung diseases; mediastinal diseases; mesothelioma; skin; thoracic diseases; melanoma; dermatopathology; clinical dermatology; squamous cell carcinoma

  • Roberto Cuomo

    University of Siena, ITALY

    Interests: melanoma, squamous cell carcinoma, basal cell carcinoma, skin cancer, rare skin cancer, breast cancer

  • Marzia Di Donato

    University of Campania “L.Vanvitelli”, ITALY

    Interests: androgens/androgen receptor axis, steroids; growth factors, receptors, signal transduction, cell cycle, invasiveness, breast and prostate cancer, tumor microenvironment, cell differentiation, cell biology, migration, cell proliferation

  • Meran Keshawa Ediriweera

    University of Colombo, SRI LANKA

    Interests: biochemistry, cancer, cancer epigenetics, pharmacognosy, ethnopharmacology

  • Abu Hazafa

    University of Salerno, ITALY

    Interests: CAR-T cells, tumor immunotherapy, cancer biology, natural product drug discovery

  • Chen Li

    Free University of Berlin, GERMANY

    Interests: fundamental and experimental pharmacology; cancer immunotherapy

  • Fernando Mendes

    Instituto Politécnico de Coimbra, PORTUGAL

    Interests: lung cancer, lymphoma, blood bank, immunhematology, cancer treatement, radiotherapy, immune system, forsman blood group

  • Jialin Meng

    The First Affiliated Hospital of Anhui Medical University, CHINA

    Interests: clinical and basic research on prostate diseases, chronic prostatitis and prostate cancer

  • Romeo Patini

    Catholic university of Sacred Heart Rome, ITALY

    Interests: molecular biology, biological fluids proteomics

  • Emanuele Perrone

    Fondazione Policlinico Agostino Gemelli IRCCS, ITALY

    Interests: gynecology oncology, cervical, ovarian and endometrial cancer

  • Le Su

    Jacksonville State University, USA

    Interests: epigenetics, childhood cancer (molecular and cellular basis of childhood sarcomas), targeted therapy

  • Yaying Sun

    Huashan Hospital, CHINA

    Interests: multi-organic crosstalk in terms of musculoskeletal and immune system, development of novel nanomedicine delivery system, prognostic factors and predictive model establishment of different cancers

  • Ziheng Wang

    Nantong University, CHINA

    Interests: bioinformatics analysis; clinical problems with machine learning; oncology using single-cell omics strategies; basic and clinical research studies; molecular pathology; etiology and pathogenesis; biomarkers; genomics; transcriptome; proteomics; metabonomics; prognosis

  • Hao Zhang

    Chongqing Medical University, CHINA

    Interests: tumor microenvironment; cancer immunotherapy; small molecule drug; molecular mechanism; bioinformatics; target therapy; signal transduction

  • Zhongbao Zhou

    Urology Surgery, Beijing Tian Tan Hospital, Capital Medical University, CHINA

    Interests: Renal Cell Carcinoma; Bladder Cancer; Prostatic Cancer

  • Yutian Zou

    Sun Yat-sen University Cancer Center, CHINA

    Interests: Breast cancer; Immunotherapy; Tumor microenvironment; Anti-HER2 therapy; Drug resistance; Single-cell sequencing; CRISPR; CircRNA; Cell death; Ferroptosis; Organoid; Bioinformatics

Editorial Advisory Board
  • L. J. Appleman

    University of Pittsburgh, USA

    Interests: tumor immunology, clinical trial of an autologous dendritic cell vaccine, cancer immunotherapy

  • N. Bahary

    University of Pittsburgh, USA

    Interests: oncologists diagnose, cancer surgeons, or surgical oncologists, remove tumors, while medical oncologists treat cancers with chemotherapy, gastrointestinal cancer

  • J. R. Bertino

    Rutgers Cancer Institute of New Jersey, USA

    Interests: cancer biology, lymphomas, antimetabolites

  • J. H. Beumer

    Hillman Cancer Center, USA

    Interests: pharmacology, toxicology

  • M. Boyiadzis

    University of Pittsburgh, USA

    Interests: internal medicine, hematology/oncology, medical oncology

  • A. H. Calvert

    University of Newcastle upon Tyne, UK

    Interests: tumor biology

  • Y.-C. Cheng

    Yale University School of Medicine, USA

    Interests: pharmacology, antiviral drugs against HBV, HIV, EBV, and HCV, as well as the discovery of antivirals with unique mode of action against those viruses.

  • M. S. Copur

    University of Nebraska, USA

    Interests: medical oncology, hematology

  • A. Deguchi

    Tokyo Women’s Medical University, JAPAN

    Interests: pharmacology, cancer research

  • X. Ding

    Nanjing Medical University, CHINA

    Interests: digestive diseases

  • S. Gantsev

    Bashkirian State Medical University, RUSSIAN

    Interests: pharmacology

  • Y. Horiguchi

    Tokyo Medical University, JAPAN

    Interests: biomaterials and bioengineering

  • M. Imoto

    Keio University, JAPAN

    Interests: nanotechnology, materials, chemical biology

  • H. Kakeya

    Kyoto University, JAPAN

    Interests: chemical biology

  • M. Kawatani

    RIKEN, JAPAN

    Interests: interdisciplinary science & engineering, biological sciences

  • E. Kikuchi

    Keio University, JAPAN

    Interests: neuropsychiatry

  • K. P. Kim

    University of Ulsan College of Medicine, KOREA

    Interests: pre-medicine, clinical pharmacology

  • T. W. Kim

    University of Ulsan College of Medicine, KOREA

    Interests: medicine

  • A. Krishnamurthy

    University of Pittsburgh, USA

    Interests: diagnosis and multidisciplinary management of gastrointestinal (GI) cancers

  • Y. Li

    Sorrento Therapeutics, USA

    Interests: tumor immunology, molecular biology, medical genetics and clinical medicine

  • Y. Lin

    Aichi Medical University, JAPAN

    Interests: pancreatic cancer, gastric cancer, epidemiologic studies, esophageal cancer

  • D. Longley

    Queen’s University, UK

    Interests: apoptosis proteins, birinapant, poptosis

  • J. Neuzil

    Griffith University, Gold Coast Campus, AUSTRALIA

    Interests: medical microbiology, oncology and carcinogenesis

  • O. Ohno

    Kogakuin University, JAPAN

    Interests: immunology

  • T. Ohsugi

    Rakuno Gakuen University, JAPAN

    Interests: genetically modified mice, MNVmouse norovirusspecific pathogen-freemicrobiological monitoring HTLV-1 animal modeltaxTransgenic miceATLL

  • M. Oya

    Keio University, JAPAN

    Interests: urology

  • M. Ozaki

    Hokkaido University, JAPAN

    Interests: biomedical imaging, oxidative stress, non-alcoholic fatty liver disease

  • A. Di Paolo

    University of Pisa, ITALY

    Interests: pharmacology, clinical pharmacokinetics and PK/PD of antineoplastic and antiinfective drugs

  • J. Robert

    Université de Bordeaux, FRANCE

    Interests: pharmacocinétique, métabolisme et résistance, pharmacologie cellulaire et moléculaire, pharmacogénétique

  • M. Rudek

    Johns Hopkins University, USA

    Interests: clinical pharmacology of anticancer agents; early phase drug development; drug tolerability in cancer patients with HIV/AIDS; drug tolerability in cancer patients with organ dysfunction; blood-brain barrier penetration of drugs.

  • Y. Sasazawa

    Juntendo University, JAPAN

    Interests: proteomics and biomolecular science

  • J. H. M. Schellens

    Netherlands Cancer Institute, the Netherlands

    Interests: clinical pharmacology

  • J. C. Schmitz

    University of Pittsburgh, USA

    Interests: pharmacodynamic, the mechanism(s) of action of quassinoids on colorectal cancer cells and tumors

  • K. Sidthipong

    Mahidol University, THAILAND

    Interests: biology, chemistry, bioorganic & medicinal chemistry letters

  • S. Simizu

    Keio University, JAPAN

    Interests: cancer, molecular target therapy, inflammation, chemical biology

  • M. Takeiri

    Ivy Cosmetics, JAPAN

    Interests: osteoclasts

  • E. Tashiro

    Showa Pharmaceutical University, JAPAN

    Interests: nature chemical biology

  • T. Ueno

    Tsukuba University, JAPAN

    Interests: materials science

  • P. Workman

    CRC Center for Cancer Therapeutics, UK

    Interests: drug discovery, molecular pharmacology and chemical biology approaches

  • M. Yamamoto

    Waseda University, JAPAN

    Interests: infrared, FTIR analysis, infrared spectrophotom

  • L. Zhang

    University of Pittsburgh, USA

    Interests: pharmacology and chemical Biology

Emeritus Editor-in-Chief
  • Late Prof. Kazuo Umezawa

    Aichi Medical University, JAPAN

    Interests: CPR, resuscitation, critical care medicine, intensive care medicine, hypothermia, emergency management, emergency treatment, sepsis, ventilation, ICU

Share Link